Growth Metrics

Mannkind (MNKD) Non-Current Assets (2010 - 2026)

Mannkind (MNKD) reported Non-Current Assets of $493.2 million for Q1 2026, up 261.6% year-over-year from $136.4 million in Q1 2025, and down 1.47% on a QoQ basis from $500.6 million in Q4 2025.

Mannkind (MNKD) has 17 years of Non-Current Assets data on file, last reported at $493.2 million in Q1 2026.

  • Quarterly Non-Current Assets rose 261.6% year-over-year to $493.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 billion (up 144.46% YoY) and the FY2025 annual result came in at $500.6 million, up 298.77% from the prior year.
  • Non-Current Assets fell to $493.2 million in Q1 2026 per MNKD's latest filing, from $500.6 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $500.6 million in Q4 2025 and bottomed at $60.4 million in Q4 2022.
  • The 5-year median for Non-Current Assets is $117.9 million (2024), against an average of $152.0 million.
  • Peak annual rise in Non-Current Assets reached 299.66% in 2022, while the deepest fall reached 40.61% in 2022.
  • Tracing MNKD's Non-Current Assets over 5 years: stood at $60.4 million in 2022, then jumped by 68.59% to $101.8 million in 2023, then climbed by 23.31% to $125.5 million in 2024, then jumped by 298.77% to $500.6 million in 2025, then retreated by 1.47% to $493.2 million in 2026.
  • Per Business Quant, the three latest MNKD Non-Current Assets figures stand at $493.2 million (Q1 2026), $500.6 million (Q4 2025), and $135.8 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 4.56 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 62,953.78
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 486.60 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 5.83 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 30.30 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 14.75 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 22.66 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 910.24 Mn
10 Mannkind 1.09 Bn 956.66 Mn 82.66 Mn 493.24 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 493.24 Mn
Dec 31, 2025 500.60 Mn
Sep 30, 2025 135.80 Mn
Jun 30, 2025 132.67 Mn
Mar 31, 2025 136.40 Mn
Dec 31, 2024 125.54 Mn
Sep 30, 2024 136.54 Mn
Jun 30, 2024 117.90 Mn
Mar 31, 2024 97.78 Mn
Dec 31, 2023 101.81 Mn
Sep 30, 2023 94.75 Mn
Jun 30, 2023 83.19 Mn
Mar 31, 2023 74.84 Mn
Dec 31, 2022 60.39 Mn
Sep 30, 2022 75.46 Mn
Jun 30, 2022 92.32 Mn
Mar 31, 2022 124.05 Mn
Dec 31, 2021 101.67 Mn
Sep 30, 2021 79.00 Mn
Jun 30, 2021 72.89 Mn
Mar 31, 2021 31.04 Mn
Dec 31, 2020 29.13 Mn
Sep 30, 2020 29.34 Mn
Jun 30, 2020 30.20 Mn
Mar 31, 2020 30.86 Mn
Dec 31, 2019 32.97 Mn
Sep 30, 2019 33.40 Mn
Jun 30, 2019 31.96 Mn
Mar 31, 2019 31.27 Mn
Dec 31, 2018 25.85 Mn
Sep 30, 2018 25.83 Mn
Jun 30, 2018 26.36 Mn
Mar 31, 2018 26.85 Mn
Dec 31, 2017 27.36 Mn
Sep 30, 2017 27.85 Mn
Jun 30, 2017 28.44 Mn
Mar 31, 2017 29.09 Mn
Dec 31, 2016 29.58 Mn
Sep 30, 2016 47.53 Mn
Jun 30, 2016 48.67 Mn
Mar 31, 2016 49.13 Mn
Dec 31, 2015 49.76 Mn
Sep 30, 2015 206.78 Mn
Jun 30, 2015 206.72 Mn
Mar 31, 2015 201.73 Mn
Dec 31, 2014 193.29 Mn
Sep 30, 2014 193.30 Mn
Jun 30, 2014 191.40 Mn
Mar 31, 2014 185.15 Mn
Dec 31, 2013 182.37 Mn
Sep 30, 2013 188.28 Mn
Jun 30, 2013 180.27 Mn
Mar 31, 2013 182.91 Mn
Dec 31, 2012 184.50 Mn
Sep 30, 2012 187.13 Mn
Jun 30, 2012 190.05 Mn
Mar 31, 2012 191.71 Mn
Dec 31, 2011 193.73 Mn
Sep 30, 2011 196.99 Mn
Jun 30, 2011 201.50 Mn
Dec 31, 2010 203.30 Mn